Renaissance Technologies - PROTAGONIST THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,774
-65.0%
226,268
-42.0%
0.01%
-62.5%
Q2 2023$10,779
-32.2%
390,267
-43.5%
0.02%
-23.8%
Q1 2023$15,890
+462.7%
690,867
+166.9%
0.02%
+425.0%
Q4 2022$2,824
-99.9%
258,867
-35.2%
0.00%
-20.0%
Q3 2022$3,370,000
+31.9%
399,767
+23.8%
0.01%
+66.7%
Q2 2022$2,554,000
+454.0%
322,867
+1558.5%
0.00%
+200.0%
Q1 2022$461,000
-36.1%
19,467
-45.6%
0.00%0.0%
Q4 2020$722,000
-89.0%
35,797
-89.4%
0.00%
-85.7%
Q3 2020$6,582,000
-30.0%
336,700
-36.7%
0.01%
-12.5%
Q2 2020$9,400,000
+131.4%
532,300
-7.5%
0.01%
+100.0%
Q1 2020$4,062,000
-6.8%
575,400
-6.9%
0.00%
+33.3%
Q4 2019$4,358,000
-34.6%
618,124
+11.4%
0.00%
-50.0%
Q3 2019$6,667,000
+7.5%
555,100
+8.4%
0.01%
+20.0%
Q2 2019$6,204,000
+21.9%
512,300
+26.5%
0.01%0.0%
Q1 2019$5,091,000
+122.6%
405,000
+19.2%
0.01%
+66.7%
Q4 2018$2,287,000
-58.6%
339,800
-36.7%
0.00%
-50.0%
Q3 2018$5,528,000
+51.0%
537,200
+1.3%
0.01%
+200.0%
Q2 2018$3,662,000
+717.4%
530,500
+916.3%
0.00%
Q1 2018$448,000
+52.4%
52,200
+100.9%
0.00%
Q2 2017$294,00025,9890.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$20,647,0006.08%
Bain Capital Life Sciences Investors, LLC 2,260,572$19,057,0002.28%
Kynam Capital Management, LP 519,212$4,377,0000.92%
RTW INVESTMENTS, LP 4,176,837$35,211,0000.81%
Tri Locum Partners LP 199,500$1,682,0000.46%
Birchview Capital, LP 38,000$320,0000.22%
Gratus Capital, LLC 206,113$1,738,0000.18%
FARALLON CAPITAL MANAGEMENT LLC 3,651,887$30,785,0000.17%
PDT Partners, LLC 126,038$1,063,0000.16%
FOX RUN MANAGEMENT, L.L.C. 40,683$343,0000.13%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders